Colinz Laboratories Declares Non-Applicability of Related Party Transaction Rules for Q4 FY26

Colinz laboratories Limited has officially declared to the Bombay Stock Exchange that it is not required to comply with Related Party Transaction disclosure requirements for the quarter ended 31st March, 2026. The declaration was made pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Exemption Details

The company has claimed exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015. Under this provision, compliance with several regulatory requirements becomes non-applicable to the company, including:

Provisions specified in Regulations 17 to 27
Clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46
Para C, D and E of Schedule V of SEBI (LODR) Regulations, 2015

Parameter:	Details
BSE Code:	531210
CIN:	L24200MH1986PLC041128
Quarter Ended:	31st March, 2026
Declaration Date:	03-04-2026

Declaration Authority

The declaration was signed by Vijaya Mani, Director of Colinz Laboratories Limited, with DIN 11363910. The document was submitted with the company's official seal to the Bombay Stock Exchange at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.

Regulatory Context

The exemption under Regulation 15(2)(a) allows certain companies to be relieved from various compliance requirements under the SEBI (LODR) Regulations, 2015. This includes the mandatory disclosure of Related Party Transactions that would otherwise be required under Regulation 23(9) for the specified quarter.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+4.78%	+5.93%	+4.81%	+19.54%	-17.51%	+421.65%

Colinz Laboratories Limited has officially declared the non-applicability of SEBI LODR Regulation 32 for the quarter ended 31.03.2026. The company communicated this regulatory update to BSE Limited through a formal declaration dated 3rd April, 2026.

Regulatory Declaration Details

The declaration specifically addresses Regulation 32 of The SEBI (LODR) Regulations, 2015, which deals with statement of deviation or variation for proceeds of various capital raising instruments. The company confirmed that this regulation does not apply to its operations for the specified quarter.

Parameter	Details
Quarter Period	Ended 31.03.2026
Declaration Date	3rd April, 2026
Regulation	SEBI LODR Regulation 32
BSE Code	531210
CIN	L24200MH1986PLC041128

Reason for Non-Applicability

Colinz Laboratories stated that Regulation 32 is not applicable since the company has not undertaken any of the following activities during the quarter:

Public issue
Rights issue
Preferential issue
Qualified Institutional Placement (QIP)

Corporate Information

The declaration was signed by Vijaya Mani, Director of the company, bearing DIN: 11363910. The company maintains its corporate office at A/101, Pratik Estate, Next to Fortis Hospital, Mulund Link Road, Mumbai - 400 078, and can be contacted through multiple communication channels including email addresses colinzlabs@yahoo.com and colinzlabs@gmail.com .

This regulatory compliance declaration ensures transparency with stock exchanges and regulatory authorities regarding the company's capital structure activities during the quarter ended 31.03.2026.